Incyte (INCY) Accounts Payables (2010 - 2026)
Incyte (INCY) reported Accounts Payables of $228.6 million for Q1 2026, up 16.92% on a YoY basis from $195.5 million in Q1 2025, and up 8.9% quarter-over-quarter from $209.9 million in Q4 2025.
Incyte (INCY) Accounts Payables (2010 - 2026) Analysis & Trends
Incyte has reported Accounts Payables for 17 years, with the latest figure at $228.6 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 16.92% year-over-year to $228.6 million; the trailing twelve-month figure through Mar 2026 stood at $228.6 million (up 16.92% YoY), and the FY2025 full-year result was $209.9 million, up 6.32% from the prior year.
- Accounts Payables for Q1 2026 stood at $228.6 million, up from $209.9 million in the prior quarter.
- The five-year high for Accounts Payables was $277.5 million in Q4 2022, with the low at $55.6 million in Q1 2023.
- Historically, Accounts Payables has averaged $175.5 million across 5 years, with a median of $171.9 million in 2025.
- Annual changes were most pronounced in 2023 — Accounts Payables plunged 63.53% — and 2024, when it jumped 195.22%.
- Incyte's Accounts Payables stood at $277.5 million in 2022, then plunged by 60.51% to $109.6 million in 2023, then surged by 80.17% to $197.5 million in 2024, then rose by 6.32% to $209.9 million in 2025, then advanced by 8.9% to $228.6 million in 2026.
- The last three Accounts Payables figures came in at $228.6 million (Q1 2026), $209.9 million (Q4 2025), and $171.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 228.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228.62 Mn |
| Dec 31, 2025 | 209.94 Mn |
| Sep 30, 2025 | 171.93 Mn |
| Jun 30, 2025 | 241.09 Mn |
| Mar 31, 2025 | 195.54 Mn |
| Dec 31, 2024 | 197.47 Mn |
| Sep 30, 2024 | 178.71 Mn |
| Jun 30, 2024 | 148.17 Mn |
| Mar 31, 2024 | 164.24 Mn |
| Dec 31, 2023 | 109.60 Mn |
| Sep 30, 2023 | 139.41 Mn |
| Jun 30, 2023 | 155.54 Mn |
| Mar 31, 2023 | 55.63 Mn |
| Dec 31, 2022 | 277.55 Mn |
| Sep 30, 2022 | 163.18 Mn |
| Jun 30, 2022 | 194.77 Mn |
| Mar 31, 2022 | 152.55 Mn |
| Dec 31, 2021 | 172.11 Mn |
| Sep 30, 2021 | 114.51 Mn |
| Jun 30, 2021 | 122.10 Mn |